
One Biosciences
One Biosciences is a French biotech startup leveraging single-cell multi-omics and AI to discover novel drug targets for complex diseases.
About
One Biosciences is a biotechnology company based in France that utilizes single-cell multi-omics data and artificial intelligence to identify new therapeutic targets. Their approach focuses on understanding disease mechanisms at a cellular level to develop innovative treatments for complex diseases, including inflammatory and autoimmune conditions.
Key facts
At-a-glance profile data
- Website
- onebiosciences.fr
- Headquarters
- Paris, France
- Founded
- 2026
- Total funding
- -
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 11 Sept 2026 | Funding Round | Undisclosed | - |
Tech stack
Detected on onebiosciences.fr, last scanned 13 Oct 2026. Run your own scan
- Frontend
- Tailwind CSS
- SEO
- Yoast SEO
- CMS / Builders
- WordPress
- Email provider
- Microsoft 365
Frequently asked
Is One Biosciences trustworthy and reputable?
StartupHub's Data Trust & Reputation score for One Biosciences is 80 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
